The present study showed that the concentration of HE4 in ovarian cancer patients was significantly higher than that in benign ovarian tumor and normal control group (p<0.001), and no statistically significant differences was observed (p>0.05) between the benign ovarian tumors and normal control group. The gene discussed is WFDC2; the disease is ovarian cancer.